AAAAAA

   
Results: 1-9 |
Results: 9
Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices
Authors: Koolwijk, P Sidenius, N Peters, E Sier, CFM Hanemaaijer, R Blasi, F van Hinsbergh, VWM
Citation: P. Koolwijk et al., Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices, BLOOD, 97(10), 2001, pp. 3123-3131
Enhanced release of soluble urokinase receptor by endothelial cells in contact with peripheral blood cells
Authors: Mustjoki, S Sidenius, N Vaheri, A
Citation: S. Mustjoki et al., Enhanced release of soluble urokinase receptor by endothelial cells in contact with peripheral blood cells, FEBS LETTER, 486(3), 2000, pp. 237-242
Shedding and cleavage of the urokinase receptor (uPAR): identification andcharacterisation of uPAR fragments in vitro and in vivo
Authors: Sidenius, N Sier, CFM Blasi, F
Citation: N. Sidenius et al., Shedding and cleavage of the urokinase receptor (uPAR): identification andcharacterisation of uPAR fragments in vitro and in vivo, FEBS LETTER, 475(1), 2000, pp. 52-56
Domain 1 of the urokinase receptor (uPAR) is required for uPAR-mediated cell binding to vitronectin
Authors: Sidenius, N Blasi, F
Citation: N. Sidenius et F. Blasi, Domain 1 of the urokinase receptor (uPAR) is required for uPAR-mediated cell binding to vitronectin, FEBS LETTER, 470(1), 2000, pp. 40-46
Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy
Authors: Mustjoki, S Sidenius, N Sier, CFM Blasi, F Elonen, E Alitalo, R Vaheri, A
Citation: S. Mustjoki et al., Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy, CANCER RES, 60(24), 2000, pp. 7126-7132
Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection
Authors: Sidenius, N Sier, CFM Ullum, H Pedersen, BK Lepri, AC Blasi, F Eugen-Olsen, J
Citation: N. Sidenius et al., Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection, BLOOD, 96(13), 2000, pp. 4091-4095
Tissue-specific posttranscriptional downregulation of expression of the S100A4(mts1) gene in transgenic animals
Authors: Ambartsumian, N Klingelhofer, J Grigorian, M Karlstrom, O Sidenius, N Georgiev, G Lukanidin, E
Citation: N. Ambartsumian et al., Tissue-specific posttranscriptional downregulation of expression of the S100A4(mts1) gene in transgenic animals, INVAS METAS, 18(2), 1999, pp. 96-104
Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance
Authors: Sier, CFM Sidenius, N Mariani, A Aletti, G Agape, V Ferrari, A Casetta, G Stephens, RW Brunner, N Blasi, F
Citation: Cfm. Sier et al., Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance, LAB INV, 79(6), 1999, pp. 717-722
In vivo inhibition of NF-kappa B in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoiesis
Authors: Ferreira, V Sidenius, N Tarantino, N Hubert, P Chatenoud, L Blasi, F Korner, M
Citation: V. Ferreira et al., In vivo inhibition of NF-kappa B in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoiesis, J IMMUNOL, 162(11), 1999, pp. 6442-6450
Risultati: 1-9 |